China Biologic Products Stock Price, News & Analysis (NASDAQ:CBPO)

$81.43 0.92 (1.14 %)
(As of 01/21/2018 04:00 PM ET)
Previous Close$81.43
Today's Range$80.01 - $82.03
52-Week Range$72.21 - $120.46
Volume103,447 shs
Average Volume145,130 shs
Market Capitalization$2.70 billion
P/E Ratio20.51
Dividend YieldN/A
Beta1.8

About China Biologic Products (NASDAQ:CBPO)

China Biologic Products logoChina Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

Receive CBPO News and Ratings via Email

Sign-up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CBPO
CUSIPN/A
Phone86-10-6598-3111

Debt

Debt-to-Equity RatioN/A
Current Ratio6.45%
Quick Ratio3.92%

Price-To-Earnings

Trailing P/E Ratio20.5113350125945
Forward P/E Ratio18.34
P/E Growth1.03

Sales & Book Value

Annual Sales$341.17 million
Price / Sales7.91
Cash Flow$4.34 per share
Price / Cash18.78
Book Value$19.23 per share
Price / Book4.23

Profitability

Trailing EPS$3.97
Net Income$104.77 million
Net Margins31.29%
Return on Equity21.49%
Return on Assets18.58%

Miscellaneous

Employees1,799
Outstanding Shares33,130,000

China Biologic Products (NASDAQ:CBPO) Frequently Asked Questions

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

How were China Biologic Products' earnings last quarter?

China Biologic Products Holdings, Inc. (NASDAQ:CBPO) announced its quarterly earnings results on Wednesday, November, 1st. The biopharmaceutical company reported $1.11 earnings per share for the quarter, missing the consensus estimate of $1.30 by $0.19. China Biologic Products had a net margin of 31.29% and a return on equity of 21.49%. View China Biologic Products' Earnings History.

Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2018?

3 brokerages have issued twelve-month target prices for China Biologic Products' shares. Their predictions range from $135.00 to $140.00. On average, they expect China Biologic Products' stock price to reach $137.50 in the next twelve months. View Analyst Ratings for China Biologic Products.

Who are some of China Biologic Products' key competitors?

Who are China Biologic Products' key executives?

China Biologic Products' management team includes the folowing people:

  • David Gao, Chairman of the Board, President, Chief Executive Officer
  • Ming Yang CPA, Chief Financial Officer
  • Zhijing Liu, Corporate Vice President
  • Ming Yin, Senior Corporate Vice President
  • Gang Yang, Corporate Vice President, General Manager of Guizhou Taibang
  • David Hui Li, Director
  • Joseph J. Chow, Independent Director
  • Wenfang Liu, Independent Director
  • Yungang Lu, Independent Director
  • Xiaosheng Shao, Independent Director

Who owns China Biologic Products stock?

China Biologic Products' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include PW MEDTECH GROUP LTD (16.70%), PW MEDTECH GROUP LTD (16.70%), Wasatch Advisors Inc. (0.69%) and Vontobel Asset Management Inc. (0.27%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Sean Shao, Wenfang Liu, Wp X Biologics Llc and Zhijing Cbpo Liu. View Institutional Ownership Trends for China Biologic Products.

Who bought China Biologic Products stock? Who is buying China Biologic Products stock?

China Biologic Products' stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc. and Vontobel Asset Management Inc.. View Insider Buying and Selling for China Biologic Products.

How do I buy China Biologic Products stock?

Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Biologic Products' stock price today?

One share of China Biologic Products stock can currently be purchased for approximately $81.43.

How big of a company is China Biologic Products?

China Biologic Products has a market capitalization of $2.70 billion and generates $341.17 million in revenue each year. The biopharmaceutical company earns $104.77 million in net income (profit) each year or $3.97 on an earnings per share basis. China Biologic Products employs 1,799 workers across the globe.

How can I contact China Biologic Products?

China Biologic Products' mailing address is JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD 18TH FLOOR, BEIJING F4, 100125. The biopharmaceutical company can be reached via phone at 86-10-6598-3111 or via email at [email protected]


MarketBeat Community Rating for China Biologic Products (CBPO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  186 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  342
MarketBeat's community ratings are surveys of what our community members think about China Biologic Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

China Biologic Products (NASDAQ:CBPO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.672.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $137.50$137.50$137.50$137.50
Price Target Upside: 41.69% upside41.69% upside41.69% upside26.72% upside

China Biologic Products (NASDAQ:CBPO) Consensus Price Target History

Price Target History for China Biologic Products (NASDAQ:CBPO)

China Biologic Products (NASDAQ:CBPO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2017Jefferies GroupReiterated RatingBuyLowView Rating Details
5/30/2017Goldman Sachs GroupInitiated CoverageNeutral -> NeutralMediumView Rating Details
3/3/2017Morgan StanleyReiterated RatingOverweight$135.00N/AView Rating Details
7/5/2016Credit Suisse GroupUpgradeNeutral -> OutperformN/AView Rating Details
(Data available from 1/21/2016 forward)

Earnings

China Biologic Products (NASDAQ:CBPO) Earnings History and Estimates Chart

Earnings by Quarter for China Biologic Products (NASDAQ:CBPO)

China Biologic Products (NASDAQ CBPO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3 2017$1.30$1.11ViewN/AView Earnings Details
8/2/20176/30/2017$1.30$1.35$97.33 million$89.28 millionViewListenView Earnings Details
5/3/2017Q1 2017$1.24$1.32ViewN/AView Earnings Details
2/23/2017Q416$0.84$0.95$76.61 million$77.60 millionViewN/AView Earnings Details
11/2/2016Q316$1.05$1.22$88.46 million$86.50 millionViewN/AView Earnings Details
8/4/2016Q216$1.16$1.10$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$0.99$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87$70.35 millionViewN/AView Earnings Details
3/4/2015Q4 2014$0.48ViewN/AView Earnings Details
11/5/2014Q4 14$0.43$0.48$63.00 million$68.92 millionViewN/AView Earnings Details
8/5/2014Q2 2014$0.79ViewN/AView Earnings Details
5/6/2014Q1 2014$0.70ViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.58ViewN/AView Earnings Details
5/8/2013Q1 2013$0.53ViewN/AView Earnings Details
3/13/2013Q4 2012$0.21ViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
8/9/2012Q2 2012$0.46ViewN/AView Earnings Details
5/8/2012Q1 2012$0.39ViewN/AView Earnings Details
3/12/2012Q4 2011$0.28ViewN/AView Earnings Details
11/7/2011Q3 2011$0.42ViewN/AView Earnings Details
8/9/2011Q2 2011($0.06)ViewN/AView Earnings Details
5/9/2011Q1 2011$0.26$0.25ViewN/AView Earnings Details
3/31/2011Q4 2010$0.39$0.43ViewN/AView Earnings Details
11/16/2010Q3 2010$0.32$0.39ViewN/AView Earnings Details
8/16/2010Q2 2010$0.44$0.40ViewN/AView Earnings Details
5/17/2010Q1 2010$0.28$0.27ViewN/AView Earnings Details
3/23/2010Q4 2009$0.23$0.45ViewN/AView Earnings Details
11/16/2009Q3 2009$0.33ViewN/AView Earnings Details
8/17/2009Q2 2009$0.38ViewN/AView Earnings Details
5/18/2009Q1 2009$0.20ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

China Biologic Products (NASDAQ:CBPO) Earnings Estimates

Current Year EPS Consensus Estimate: $4.44 EPS
Next Year EPS Consensus Estimate: $5.74 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

China Biologic Products (NASDAQ CBPO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.73%
Institutional Ownership Percentage: 54.70%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)

China Biologic Products (NASDAQ CBPO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2017Zhijing Cbpo LiuInsiderSell7,500$116.49$873,675.0010,969View SEC Filing  
3/2/2017Sean ShaoDirectorSell20,000$100.78$2,015,600.0036,000View SEC Filing  
3/1/2017David GaoCEOSell116,653$100.63$11,738,791.39449,396View SEC Filing  
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.4424,782View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.003,383View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.1252,282View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.5251,419View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00718View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.0014,000View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60377,000View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66472,991View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78485,882View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24557,000View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00616,542View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00616,542View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.0024,782View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.4013,467View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.3224,782View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.343,283View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

China Biologic Products (NASDAQ CBPO) News Headlines

Source:
DateHeadline
 Brokerages Expect China Biologic Products Holdings, Inc. (CBPO) to Announce $1.11 EPS Brokerages Expect China Biologic Products Holdings, Inc. (CBPO) to Announce $1.11 EPS
www.americanbankingnews.com - January 16 at 11:42 AM
Brokerages Anticipate China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPSBrokerages Anticipate China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPS
www.americanbankingnews.com - January 14 at 12:02 AM
Brokerages Expect China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPSBrokerages Expect China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPS
www.americanbankingnews.com - January 10 at 5:08 AM
China Biologic Announces Corporate Update - PR Newswire (press release)China Biologic Announces Corporate Update - PR Newswire (press release)
www.prnewswire.com - January 8 at 5:00 PM
Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Improved Earnings Growth In Recent Times?Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Improved Earnings Growth In Recent Times?
finance.yahoo.com - January 8 at 5:00 PM
China Biologic to Attend the 36th Annual J.P. Morgan Healthcare ConferenceChina Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 10:11 AM
China Biologic Announces Corporate UpdateChina Biologic Announces Corporate Update
finance.yahoo.com - January 8 at 10:11 AM
Analysts Anticipate China Biologic Products Holdings, Inc. (CBPO) to Announce $1.11 Earnings Per ShareAnalysts Anticipate China Biologic Products Holdings, Inc. (CBPO) to Announce $1.11 Earnings Per Share
www.americanbankingnews.com - January 6 at 9:56 AM
China Biologic Announces Completion of Acquisition of TianXinFu from PWMChina Biologic Announces Completion of Acquisition of TianXinFu from PWM
finance.yahoo.com - January 3 at 9:18 AM
How Do Analysts See China Biologic Products Holdings Inc (NASDAQ:CBPO) Performing Over The Next Few Years?How Do Analysts See China Biologic Products Holdings Inc (NASDAQ:CBPO) Performing Over The Next Few Years?
finance.yahoo.com - January 1 at 4:50 PM
 Analysts Expect China Biologic Products Holdings, Inc. (CBPO) Will Post Earnings of $1.11 Per Share Analysts Expect China Biologic Products Holdings, Inc. (CBPO) Will Post Earnings of $1.11 Per Share
www.americanbankingnews.com - December 30 at 3:14 PM
China Biologic Products Holdings, Inc. – Value Analysis (NASDAQ:CBPO) : December 29, 2017China Biologic Products Holdings, Inc. – Value Analysis (NASDAQ:CBPO) : December 29, 2017
finance.yahoo.com - December 29 at 4:49 PM
China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : December 28, 2017China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : December 28, 2017
finance.yahoo.com - December 28 at 11:16 AM
China Biologic Products (CBPO) Upgraded to Sell by BidaskClubChina Biologic Products (CBPO) Upgraded to Sell by BidaskClub
www.americanbankingnews.com - December 24 at 10:02 AM
Should You Be Tempted To Buy China Biologic Products Holdings Inc (NASDAQ:CBPO) Because Of Its PE Ratio?Should You Be Tempted To Buy China Biologic Products Holdings Inc (NASDAQ:CBPO) Because Of Its PE Ratio?
finance.yahoo.com - December 22 at 7:59 PM
 China Biologic Products Holdings, Inc. (CBPO) Given $111.67 Consensus Target Price by Brokerages China Biologic Products Holdings, Inc. (CBPO) Given $111.67 Consensus Target Price by Brokerages
www.americanbankingnews.com - December 22 at 10:10 AM
China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong ProvinceChina Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province
finance.yahoo.com - December 15 at 10:27 AM
Zacks: Analysts Expect China Biologic Products Holdings, Inc. (CBPO) Will Post Earnings of $1.11 Per ShareZacks: Analysts Expect China Biologic Products Holdings, Inc. (CBPO) Will Post Earnings of $1.11 Per Share
www.americanbankingnews.com - December 13 at 11:36 AM
Has China Biologic Products Holdings Inc (CBPO) Got Enough Cash To Cover Its Short-Term Obligations?Has China Biologic Products Holdings Inc (CBPO) Got Enough Cash To Cover Its Short-Term Obligations?
finance.yahoo.com - December 7 at 5:13 PM
Analysts Expect China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPSAnalysts Expect China Biologic Products Holdings, Inc. (CBPO) to Post $1.11 EPS
www.americanbankingnews.com - December 7 at 1:44 AM
China Biologic Products (CBPO) versus Its Rivals Financial AnalysisChina Biologic Products (CBPO) versus Its Rivals Financial Analysis
www.americanbankingnews.com - December 5 at 11:36 PM
Reviewing China Biologic Products (CBPO) and Its PeersReviewing China Biologic Products (CBPO) and Its Peers
www.americanbankingnews.com - December 4 at 3:18 PM
Madrigal Pharmaceuticals (MDGL) versus China Biologic Products (CBPO) Financial ReviewMadrigal Pharmaceuticals (MDGL) versus China Biologic Products (CBPO) Financial Review
www.americanbankingnews.com - November 22 at 11:10 PM
What Do Analysts Think About China Biologic Products Holdings Inc’s (CBPO) Growth?What Do Analysts Think About China Biologic Products Holdings Inc’s (CBPO) Growth?
finance.yahoo.com - November 22 at 10:44 PM
Financial Review: China Biologic Products (CBPO) vs. Its CompetitorsFinancial Review: China Biologic Products (CBPO) vs. Its Competitors
www.americanbankingnews.com - November 22 at 3:18 AM
Brokerages Expect China Biologic Products, Inc. (CBPO) to Announce $1.11 EPSBrokerages Expect China Biologic Products, Inc. (CBPO) to Announce $1.11 EPS
www.americanbankingnews.com - November 20 at 3:36 AM
Head to Head Contrast: China Biologic Products (CBPO) and Its RivalsHead to Head Contrast: China Biologic Products (CBPO) and Its Rivals
www.americanbankingnews.com - November 17 at 5:28 PM
Comparing China Biologic Products (CBPO) & The CompetitionComparing China Biologic Products (CBPO) & The Competition
www.americanbankingnews.com - November 16 at 1:06 AM
China Biologic Products, Inc. (CBPO) Upgraded to Hold at Zacks Investment ResearchChina Biologic Products, Inc. (CBPO) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - November 15 at 7:48 PM
Calculating The Intrinsic Value Of China Biologic Products Holdings Inc (CBPO)Calculating The Intrinsic Value Of China Biologic Products Holdings Inc (CBPO)
finance.yahoo.com - November 8 at 8:02 PM
ETFs with exposure to China Biologic Products Holdings, Inc. : November 7, 2017ETFs with exposure to China Biologic Products Holdings, Inc. : November 7, 2017
finance.yahoo.com - November 7 at 7:55 PM
Zacks: Analysts Expect China Biologic Products, Inc. (CBPO) to Announce $1.02 Earnings Per ShareZacks: Analysts Expect China Biologic Products, Inc. (CBPO) to Announce $1.02 Earnings Per Share
www.americanbankingnews.com - November 6 at 9:26 PM
Zacks: China Biologic Products, Inc. (CBPO) Given Consensus Recommendation of "Strong Buy" by BrokeragesZacks: China Biologic Products, Inc. (CBPO) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - November 5 at 5:52 AM
China Biologic Products posts 3Q profitChina Biologic Products posts 3Q profit
finance.yahoo.com - November 2 at 5:48 PM
China Biologic Products posts 3Q profitChina Biologic Products posts 3Q profit
finance.yahoo.com - November 2 at 5:48 PM
BRIEF-China Biologic posts Q3 adj. earnings per share $1.38BRIEF-China Biologic posts Q3 adj. earnings per share $1.38
www.reuters.com - November 1 at 11:04 PM
China Biologic Products Inc. Reports 15% Rise In Q3 EarningsChina Biologic Products Inc. Reports 15% Rise In Q3 Earnings
www.rttnews.com - November 1 at 5:45 PM
China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017
finance.yahoo.com - November 1 at 5:45 PM
ETFs with exposure to China Biologic Products Holdings, Inc. : October 27, 2017ETFs with exposure to China Biologic Products Holdings, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 7:36 PM
China Biologic Products to Report Third Quarter of 2017 Financial ResultsChina Biologic Products to Report Third Quarter of 2017 Financial Results
finance.yahoo.com - October 25 at 6:27 PM
 Analysts Set $123.33 Target Price for China Biologic Products, Inc. (CBPO) Analysts Set $123.33 Target Price for China Biologic Products, Inc. (CBPO)
www.americanbankingnews.com - October 21 at 4:24 AM
China Biologic Products, Inc. (CBPO) Expected to Post Earnings of $1.30 Per ShareChina Biologic Products, Inc. (CBPO) Expected to Post Earnings of $1.30 Per Share
www.americanbankingnews.com - October 18 at 4:04 AM
Week In Review: Shanghai Pharma Bids In Cardinal Chinas $1.5 Billion AuctionWeek In Review: Shanghai Pharma Bids In Cardinal China's $1.5 Billion Auction
seekingalpha.com - October 15 at 4:33 PM
First Week of CBPO November 17th Options TradingFirst Week of CBPO November 17th Options Trading
www.nasdaq.com - October 13 at 5:39 PM
China Biologic Products (CBPO) Fell To A New Low After AcquisitionChina Biologic Products (CBPO) Fell To A New Low After Acquisition
www.rttnews.com - October 13 at 5:39 PM
China Biologic Products Announces Conference Call to Discuss TianXinFu AcquisitionChina Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition
finance.yahoo.com - October 13 at 5:39 PM
China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017
finance.yahoo.com - October 13 at 5:39 PM
ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 5:39 PM
China Biologic Products (CBPO) Reports Acquisition of TianXinFu ... - StreetInsider.comChina Biologic Products (CBPO) Reports Acquisition of TianXinFu ... - StreetInsider.com
www.streetinsider.com - October 13 at 3:54 AM
 China Biologic Products, Inc. (CBPO) Given $131.67 Consensus Target Price by Brokerages China Biologic Products, Inc. (CBPO) Given $131.67 Consensus Target Price by Brokerages
www.americanbankingnews.com - October 13 at 12:26 AM

SEC Filings

China Biologic Products (NASDAQ:CBPO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

China Biologic Products (NASDAQ:CBPO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

China Biologic Products (NASDAQ CBPO) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.